Upregulation of EZH2 exacerbates PAH by promoting the transformation of pulmonary VSMC into a proliferative phenotype, thereby worsening vascular remodeling and hemodynamic changes in SOD2 deficiency mice (Wang et al., 2021). This evidence concerns the gene EZH2 and pulmonary arterial hypertension.